The Metacognitions about Symptoms Control Scale: Development and Concurrent Validity

Bruce A. Fernie; Lorraine Maher-Edwards; Gabrielle Murphy; Ana V. Nikčević; Marcantonio M. Spada

doi:10.1002/cpp.1906

The Metacognitions about Symptoms Control Scale: Development and Concurrent Validity

Bruce A. Fernie, Lorraine Maher-Edwards, Gabrielle Murphy, Ana V. Nikčević, Marcantonio M. Spada

London South Bank University

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

1 Downloads (Pure)

Abstract

Objective: This paper presents the development and preliminary validation of a self-report instrument designed to measure metacognitions pertaining to symptoms control in the form of the following: (1) symptoms focusing and (2) symptoms conceptual thinking.Methods: A total of 124 patients (95 female and 29 male) presenting with chronic fatigue syndrome (CFS) contributed data to the study to test the structure and psychometric properties of the Metacognitions about Symptoms Control Scale (MaSCS).Results: A principal components factor analysis indicated that a two-factor solution best fitted the data. The factors were labelled positive and negative metacognitions about symptoms control. Further analyses revealed that both factors had good internal consistency. Correlation analyses established preliminary concurrent validity, indicating that both positive and negative metacognitions about symptoms control were significantly associated with levels of fatigue in CFS. Regression analysis revealed that positive and negative metacognitions about symptoms control significantly predicted fatigue severity when controlling for anxiety and depression.Conclusions: The newly developed instrument may help future research that examines the role of metacognitions in CFS, as well as aiding clinical assessment and case formulation.

Original language	English
Pages (from-to)	443-449
Number of pages	7
Journal	Clinical Psychology and Psychotherapy
Volume	22
Issue number	5
DOIs	https://doi.org/10.1002/cpp.1906
Publication status	Published - 1 Sept 2015

Keywords

Chronic Fatigue Syndrome
Metacognitions
Self-report Instrument
Symptoms Conceptual Thinking
Symptoms Focusing

Access to Document

10.1002/cpp.1906

Fernie, B. A. et al. The Metacognitions about Symptoms Control ScaleAccepted author manuscript, 91.3 KBLicence: CC BY 4.0

Cite this

@article{28c874d6f60941a6b9563975db7faec6,

title = "The Metacognitions about Symptoms Control Scale: Development and Concurrent Validity",

abstract = "Objective: This paper presents the development and preliminary validation of a self-report instrument designed to measure metacognitions pertaining to symptoms control in the form of the following: (1) symptoms focusing and (2) symptoms conceptual thinking.Methods: A total of 124 patients (95 female and 29 male) presenting with chronic fatigue syndrome (CFS) contributed data to the study to test the structure and psychometric properties of the Metacognitions about Symptoms Control Scale (MaSCS).Results: A principal components factor analysis indicated that a two-factor solution best fitted the data. The factors were labelled positive and negative metacognitions about symptoms control. Further analyses revealed that both factors had good internal consistency. Correlation analyses established preliminary concurrent validity, indicating that both positive and negative metacognitions about symptoms control were significantly associated with levels of fatigue in CFS. Regression analysis revealed that positive and negative metacognitions about symptoms control significantly predicted fatigue severity when controlling for anxiety and depression.Conclusions: The newly developed instrument may help future research that examines the role of metacognitions in CFS, as well as aiding clinical assessment and case formulation.",

keywords = "Chronic Fatigue Syndrome, Metacognitions, Self-report Instrument, Symptoms Conceptual Thinking, Symptoms Focusing",

author = "Fernie, {Bruce A.} and Lorraine Maher-Edwards and Gabrielle Murphy and Nik{\v c}evi{\'c}, {Ana V.} and Spada, {Marcantonio M.}",

year = "2015",

month = sep,

day = "1",

doi = "10.1002/cpp.1906",

language = "English",

volume = "22",

pages = "443--449",

journal = "Clinical Psychology and Psychotherapy",

issn = "1063-3995",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

TY - JOUR

T1 - The Metacognitions about Symptoms Control Scale

T2 - Development and Concurrent Validity

AU - Fernie, Bruce A.

AU - Maher-Edwards, Lorraine

AU - Murphy, Gabrielle

AU - Nikčević, Ana V.

AU - Spada, Marcantonio M.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Objective: This paper presents the development and preliminary validation of a self-report instrument designed to measure metacognitions pertaining to symptoms control in the form of the following: (1) symptoms focusing and (2) symptoms conceptual thinking.Methods: A total of 124 patients (95 female and 29 male) presenting with chronic fatigue syndrome (CFS) contributed data to the study to test the structure and psychometric properties of the Metacognitions about Symptoms Control Scale (MaSCS).Results: A principal components factor analysis indicated that a two-factor solution best fitted the data. The factors were labelled positive and negative metacognitions about symptoms control. Further analyses revealed that both factors had good internal consistency. Correlation analyses established preliminary concurrent validity, indicating that both positive and negative metacognitions about symptoms control were significantly associated with levels of fatigue in CFS. Regression analysis revealed that positive and negative metacognitions about symptoms control significantly predicted fatigue severity when controlling for anxiety and depression.Conclusions: The newly developed instrument may help future research that examines the role of metacognitions in CFS, as well as aiding clinical assessment and case formulation.

AB - Objective: This paper presents the development and preliminary validation of a self-report instrument designed to measure metacognitions pertaining to symptoms control in the form of the following: (1) symptoms focusing and (2) symptoms conceptual thinking.Methods: A total of 124 patients (95 female and 29 male) presenting with chronic fatigue syndrome (CFS) contributed data to the study to test the structure and psychometric properties of the Metacognitions about Symptoms Control Scale (MaSCS).Results: A principal components factor analysis indicated that a two-factor solution best fitted the data. The factors were labelled positive and negative metacognitions about symptoms control. Further analyses revealed that both factors had good internal consistency. Correlation analyses established preliminary concurrent validity, indicating that both positive and negative metacognitions about symptoms control were significantly associated with levels of fatigue in CFS. Regression analysis revealed that positive and negative metacognitions about symptoms control significantly predicted fatigue severity when controlling for anxiety and depression.Conclusions: The newly developed instrument may help future research that examines the role of metacognitions in CFS, as well as aiding clinical assessment and case formulation.

KW - Chronic Fatigue Syndrome

KW - Metacognitions

KW - Self-report Instrument

KW - Symptoms Conceptual Thinking

KW - Symptoms Focusing

U2 - 10.1002/cpp.1906

DO - 10.1002/cpp.1906

M3 - Article

C2 - 24899521

AN - SCOPUS:84942198061

SN - 1063-3995

VL - 22

SP - 443

EP - 449

JO - Clinical Psychology and Psychotherapy

JF - Clinical Psychology and Psychotherapy

IS - 5

ER -